Compare Oscar Health Inc (OSCR) vs SiTime Corporation (SITM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Oscar Health Inc vs SiTime Corporation — how do they compare? Oscar Health Inc trades at $28.84 (market cap $9.28B), while SiTime Corporation trades at $591.09 (market cap $17.66B). The key difference: SiTime Corporation is the larger of the two by market cap, and Oscar Health Inc is trading nearer its 52-week high, SiTime Corporation nearer its low. Which is the better fit depends on your goals.
| OSCR | SITM | |
|---|---|---|
Market Cap | $9.28B | $17.66B |
Sector | Health | Technology |
52-Week High | $32.18 | $901.60 |
52-Week Low | $10.85 | $190.16 |
Enterprise Value | $4.90B | $16.88B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Oscar Health (OSCR) trades at $29.60, up 1.72% with mixed technical signals showing neutral overall momentum. The company reported strong Q1 2026 earnings beat but faces profitability challenges with negative margins. Revenue growth from $11.7B in 2025 to projected $13.3B in 2026 indicates expansion, while cash flow trends show operational improvement. Analyst consensus is divided with 27% buy ratings against a $24.67 price target below current levels.
The stock presents growth potential through revenue expansion and cash flow generation, but profitability concerns and negative ROE pose significant risks. Current valuation at 0.61 P/S suggests reasonable pricing for growth, though execution on margin improvement remains critical for sustained upside.
SITM trades at $555.15, showing minimal daily movement with a 0.03% gain. The stock faces technical headwinds with a bearish moving average signal, though RSI levels suggest potential oversold conditions. Fundamentally, the company demonstrates strong revenue growth and consistent earnings beats, but operates at a net loss with negative margins. Recent developments include the completed acquisition of Renesas' timing business and strong AI-driven demand, with Q2 2026 results due August 5, 2026.
Analyst consensus remains strongly bullish with a $825 price target representing 49% upside potential. Key opportunities include accelerating AI infrastructure demand and strategic acquisitions, while risks center on continued profitability challenges and high valuation multiples. The company's growth trajectory appears promising, but investors should monitor the transition to sustainable profitability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Oscar Health Inc
Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.
Read more on OSCR →About SiTime Corporation
SiTime Corporation is a leading provider of MEMS-based silicon timing solutions used in various electronic applications. The company’s products, including oscillators, resonators, and clock ICs, are designed to replace traditional quartz-based timing devices, offering superior performance, reliability, and smaller size in harsh environments. SiTime's solutions are adopted across high-growth markets such as 5G, data centers, industrial IoT, and automotive, positioning the company as a key enabler for next-generation electronic systems.
Read more on SITM →
